Document is current

Article History

Received: 25 March 2021

Accepted: 29 March 2022

First Online: 11 April 2022

Declarations

:

: This experiment will be conducted from March 2021 to December 2021. The study protocol was approved by the Institutional Review Board of Hospital de Clínicas de Porto Alegre (protocol 180651, version 1) in August 2018. Prior to the evaluation process and after the study’s objectives, the methods and the procedures for guaranteeing their anonymity are guaranteed and explained (including the use of the data only for scientific purposes); the participants will provide written informed consent to participate, as recommended by Resolution 466/12 CNS/MS. Prior to the study, the participants will be informed about how testing and training will take place. In addition, the importance of the data obtained during the study will also be pointed out.Both the research team and the institution will keep the identities of volunteers strictly confidential. The results of the procedures evaluated in the research will be analyzed and allocated in tables, figures, and/or graphs and will be disseminated in lectures, conferences, scientific journals, or other media for transferring knowledge to society in accordance with the regulatory norms of national or international protection.The expected benefits will have great importance to participants, the institution involved, the researchers, society, and any other medium interested in advancing science, such as a better understanding of how TL behaves in patients with HFrEF, given its importance in cell senescence and the potential biomarker of disease prognosis. The expected results will demonstrate the effects of AERO on TL, which could contribute to improving rehabilitation programs and new research in the fields of exercise, cardiac rehabilitation, and health promotion.

: Not applicable.

: The authors declare that they have no competing interests.